Sale!

CAMTA1 Gene Cerebellar Ataxia Nonprogressive with Mental Retardation Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CAMTA1 gene cerebellar ataxia nonprogressive with mental retardation genetic test is a specialized diagnostic procedure aimed at identifying mutations in the CAMTA1 gene, which are associated with a rare genetic disorder. This condition is characterized by early-onset cerebellar ataxia, a disorder that affects coordination and balance, coupled with intellectual disabilities. Unlike other forms of ataxia, this particular type is nonprogressive, meaning symptoms do not worsen over time.

The test involves analyzing the patient’s DNA to detect any abnormalities or mutations in the CAMTA1 gene that may be responsible for the symptoms. This genetic testing is crucial for accurate diagnosis, enabling healthcare providers to offer appropriate management strategies and support for affected individuals and their families.

Administered by DNA Labs UAE, a leading facility in genetic diagnostics, the test ensures high accuracy and reliability. The cost of the test is set at 4400 AED, reflecting the comprehensive analysis and expertise required to conduct this specialized genetic assessment. By opting for this test, patients and their families can gain valuable insights into their condition, paving the way for a better understanding and tailored care plans.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CAMTA1 Gene Cerebellar Ataxia Nonprogressive with Mental Retardation Genetic Test

Test Details

The CAMTA1 gene cerebellar ataxia, nonprogressive, with mental retardation NGS genetic test is a diagnostic test that uses Next-Generation Sequencing (NGS) technology to detect mutations in the CAMTA1 gene. This gene is associated with a rare genetic disorder that affects the cerebellum (the part of the brain that controls movement and coordination) and causes non-progressive ataxia (lack of muscle control) and mental retardation (intellectual disability).

The test is performed on a blood or saliva sample and can identify mutations in the CAMTA1 gene that cause the disorder. The results of the test can help doctors diagnose the condition, provide appropriate treatment, and offer genetic counseling to affected individuals and their families.

NGS technology allows for the analysis of multiple genes simultaneously, making it a more efficient and cost-effective way to diagnose genetic disorders compared to traditional sequencing methods. The CAMTA1 gene cerebellar ataxia, nonprogressive, with mental retardation NGS genetic test is a valuable tool in the diagnosis and management of this rare genetic disorder.

Test Name

CAMTA1 Gene Cerebellar Ataxia Nonprogressive with Mental Retardation Genetic Test

Components

Price: 4400.0 AED

Sample Condition

Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery

3 to 4 Weeks

Method

NGS Technology

Test Type

Neurological Disorders

Doctor

Neurologist

Test Department

Genetics

Pre Test Information

Clinical History of Patient who is going for CAMTA1 Gene Cerebellar Ataxia, nonprogressive, with mental retardation NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CAMTA1 Gene Cerebellar Ataxia, nonprogressive, with mental retardation.

Test Name CAMTA1 Gene Cerebellar ataxia nonprogressive with mental retardation Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CAMTA1 Gene Cerebellar ataxia, nonprogressive, with mental retardation NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with CAMTA1 Gene Cerebellar ataxia, nonprogressive, with mental retardation
Test Details

CAMTA1 gene cerebellar ataxia, nonprogressive, with mental retardation NGS genetic test is a diagnostic test that uses Next-Generation Sequencing (NGS) technology to detect mutations in the CAMTA1 gene. This gene is associated with a rare genetic disorder that affects the cerebellum (the part of the brain that controls movement and coordination) and causes non-progressive ataxia (lack of muscle control) and mental retardation (intellectual disability).

The test is performed on a blood or saliva sample and can identify mutations in the CAMTA1 gene that cause the disorder. The results of the test can help doctors diagnose the condition, provide appropriate treatment, and offer genetic counseling to affected individuals and their families.

NGS technology allows for the analysis of multiple genes simultaneously, making it a more efficient and cost-effective way to diagnose genetic disorders compared to traditional sequencing methods. The CAMTA1 gene cerebellar ataxia, nonprogressive, with mental retardation NGS genetic test is a valuable tool in the diagnosis and management of this rare genetic disorder.